Peptides for Prevention of HIV Infection

Ivan Korendovych (Inventor)

Research output: Patent

Abstract

Two peptides that can selectively bind to SEVI and block the enhanced infectivity that results from the interaction of SEVI with HIV. The two peptides comprise the amino acid sequences FEEIVQEIEDFLENLV (SEQ. ID NO: 1) and GIGAVLEVLTTGLPALISWIEEEEQQ (SEQ. ID. NO: 2). The peptides may be administered topically, either alone or in combination with other prophylactics, agents, etc.
Original languageEnglish (US)
StatePublished - Feb 7 2019

Fingerprint

HIV Infections
Peptides
Amino Acid Sequence
HIV
N-Tyr-delta sleep-inducing peptide

Cite this

@misc{080eff73896b4a2b953e23d1d5d7d639,
title = "Peptides for Prevention of HIV Infection",
abstract = "Two peptides that can selectively bind to SEVI and block the enhanced infectivity that results from the interaction of SEVI with HIV. The two peptides comprise the amino acid sequences FEEIVQEIEDFLENLV (SEQ. ID NO: 1) and GIGAVLEVLTTGLPALISWIEEEEQQ (SEQ. ID. NO: 2). The peptides may be administered topically, either alone or in combination with other prophylactics, agents, etc.",
author = "Ivan Korendovych",
year = "2019",
month = "2",
day = "7",
language = "English (US)",
type = "Patent",

}

TY - PAT

T1 - Peptides for Prevention of HIV Infection

AU - Korendovych, Ivan

PY - 2019/2/7

Y1 - 2019/2/7

N2 - Two peptides that can selectively bind to SEVI and block the enhanced infectivity that results from the interaction of SEVI with HIV. The two peptides comprise the amino acid sequences FEEIVQEIEDFLENLV (SEQ. ID NO: 1) and GIGAVLEVLTTGLPALISWIEEEEQQ (SEQ. ID. NO: 2). The peptides may be administered topically, either alone or in combination with other prophylactics, agents, etc.

AB - Two peptides that can selectively bind to SEVI and block the enhanced infectivity that results from the interaction of SEVI with HIV. The two peptides comprise the amino acid sequences FEEIVQEIEDFLENLV (SEQ. ID NO: 1) and GIGAVLEVLTTGLPALISWIEEEEQQ (SEQ. ID. NO: 2). The peptides may be administered topically, either alone or in combination with other prophylactics, agents, etc.

M3 - Patent

ER -